✦ LIBER ✦

CV5 SHORT AND LONG TERM COST-EFFECTIVENESS ANALYSIS OF CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME WITHOUT S T-SEGMENT ELEVATION (ACS) IN SCANDINAVIAN COUNTRIES

✍ Scribed by P Lindgren; B Jönsson; J Spiesser; P Carita; S Gabriel

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term cost-effectiveness of clopidog

✍ B. Brüggenjürgen; P. Lindgren; B. Ehlken; H.-J. Rupprecht; S. N. Willich 📂 Article 📅 2006 🏛 Springer 🌐 French ⚖ 178 KB

PCV5 LONG-TERM COST-EFFECTIVENESS OF CLO

✍ B Brüggenjürgen; B Ehlken 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

PCV1 COST-EFFECTIVENESS ANALYSIS OF CLOP

✍ K Borsos; B Nagy; J Spiesser; S Gabriel; G Blaskó 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

Long-term cost-effectiveness of clopidog

✍ William S. Weintraub; Elizabeth M. Mahoney; Andre Lamy; Steven Culler; Yong Yuan 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 222 KB

Short- and Long-Term Cost-Effectiveness

✍ Xavier Badia; Héctor Bueno; José R. González Juanatey; Vicent Valentín; Marta Ru 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Influence of updated guidelines on short

✍ B. Vogel; S. Hahne; I. Kozanli; K. Kalla; R. Jarai; M. Freynhofer; P. Smetana; M 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 740 KB